Literature DB >> 1908698

A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome.

Y Inagaki1, Y Jinno-Yoshida, Y Hamasaki, H Ueki.   

Abstract

Carbonic anhydrase (CA) is an extremely basic zinc metalloenzyme with a wide phyletic distribution, and the enzyme is important for the regulation of acid-base status. A novel autoantibody reactive with carbonic anhydrase was demonstrated. Several different classes of CA are known in mammals. Using the immuno blotting method and and immun-dot analysis, we found this autoantibody to be reactive with CA in the sera from patients with Sjögren's syndrome (20.8%), including a patient with Sjögren's syndrome and renal tubular acidosis, and in patients with systemic lupus erythematosus (31.6%). The autoantibody varied in the extent of its cross-reactivity among human CA I (or B), human CA II (or C), bovine CA I, bovine CA II, rabbit CA, and dog CA. The titers continued to float and tended to parallel disease activity. Positive reactivity of autoantibody was observed on eccrine sweat glands and the distal tubules of the kidney by the indirect immunofluorescent method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908698     DOI: 10.1016/0923-1811(91)90060-b

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  25 in total

Review 1.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

2.  Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status.

Authors:  P Invernizzi; P M Battezzati; A Crosignani; P Zermiani; M Bignotto; N Del Papa; M Zuin; M Podda
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

3.  Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations.

Authors:  J R Heckenlively; N Aptsiauri; S Nusinowitz; C Peng; P A Hargrave
Journal:  Trans Am Ophthalmol Soc       Date:  1996

4.  Renal involvement in primary Sjogren's syndrome: a prospective cohort study.

Authors:  Ankit Jain; Bheemanathi Hanuman Srinivas; Dantis Emmanuel; Vikramraj K Jain; Sreejith Parameshwaran; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2018-08-23       Impact factor: 2.631

Review 5.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

6.  Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis.

Authors:  L Aparisi; A Farre; L Gomez-Cambronero; J Martinez; G De Las Heras; J Corts; S Navarro; J Mora; M Lopez-Hoyos; L Sabater; A Ferrandez; D Bautista; M Perez-Mateo; S Mery; J Sastre
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

7.  Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production.

Authors:  Yoshihito Iuchi; Futoshi Okada; Kunishige Onuma; Tadashi Onoda; Hironobu Asao; Masanobu Kobayashi; Junichi Fujii
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

8.  Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?

Authors:  D Comay; K Cauch-Dudek; D Hemphill; E Diamandis; I Wanless; E J Heathcote
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

Review 9.  Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren's syndrome: a case report and review of the literature.

Authors:  Yan Geng; Youlu Zhao; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2017-07-20       Impact factor: 2.980

Review 10.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.